Abstract
Background/Objective
We have recently developed monitoring from the injury site in patients with acute, severe traumatic spinal cord injuries to facilitate their management in the intensive care unit. This is analogous to monitoring from the brain in patients with traumatic brain injuries. This study aims to determine whether, after traumatic spinal cord injury, fluctuations in the monitored physiological, and metabolic parameters at the injury site are causally linked to changes in limb power.
Methods
This is an observational study of a cohort of adult patients with motor-incomplete spinal cord injuries, i.e., grade C American spinal injuries association Impairment Scale. A pressure probe and a microdialysis catheter were placed intradurally at the injury site. For up to a week after surgery, we monitored limb power, intraspinal pressure, spinal cord perfusion pressure, and tissue lactate-to-pyruvate ratio. We established correlations between these variables and performed Granger causality analysis.
Results
Nineteen patients, aged 22–70 years, were recruited. Motor score versus intraspinal pressure had exponential decay relation (intraspinal pressure rise to 20 mmHg was associated with drop of 11 motor points, but little drop in motor points as intraspinal pressure rose further, R2 = 0.98). Motor score versus spinal cord perfusion pressure (up to 110 mmHg) had linear relation (1.4 motor point rise/10 mmHg rise in spinal cord perfusion pressure, R2 = 0.96). Motor score versus lactate-to-pyruvate ratio (greater than 20) also had linear relation (0.8 motor score drop/10-point rise in lactate-to-pyruvate ratio, R2 = 0.92). Increased intraspinal pressure Granger-caused increase in lactate-to-pyruvate ratio, decrease in spinal cord perfusion, and decrease in motor score. Increased spinal cord perfusion Granger-caused decrease in lactate-to-pyruvate ratio and increase in motor score. Increased lactate-to-pyruvate ratio Granger-caused increase in intraspinal pressure, decrease in spinal cord perfusion, and decrease in motor score. Causality analysis also revealed multiple vicious cycles that amplify insults to the cord thus exacerbating cord damage.
Conclusion
Monitoring intraspinal pressure, spinal cord perfusion pressure, lactate-to-pyruvate ratio, and intervening to normalize these parameters are likely to improve limb power.
Similar content being viewed by others
Introduction
Traumatic spinal cord injury (TSCI) affects about 180,000 people globally each year [1]. Prognosis is generally poor. For example, more than a third of patients have paraplegia or quadriplegia, fewer than 1% are discharged neurologically normal and life expectancy is below national averages [2]. No treatment for acute TSCI has been proven to improve outcome: the effects of early surgery [3,4,5,6,7], intravenous methylprednisolone [8,9,10,11,12] or maintaining mean arterial pressure (MAP) 85–90 mmHg for a week after TSCI [13,14,15,16] remain controversial [17].
To improve the management of patients with TSCI in the intensive care unit (ICU), multi-modality monitoring from the injury site has been suggested [18]. Intraspinal pressure (ISP) and spinal cord perfusion pressure (SCPP) [19,20,21] are monitored with a pressure probe, as well as injury site metabolism with a microdialysis (MD) catheter [22, 23]. These techniques are safe and analogous to multi-modality monitoring for brain injury [24]. ISP and SCPP correlate with injury site metabolism [25], neurological status [26], and long-term neurological outcome [20], and patients with neurologically complete TSCIs have more deranged cord metabolism than those with neurologically incomplete injuries [22]. These relations between ISP, SCPP, and injury site metabolism versus neurological outcome are associations that do not imply causation.
The objective of our study is to address the question whether changes in ISP, SCPP, and injury site metabolism cause changes in limb power. This is paramount because it implies that interventions to normalize ISP, SCPP, and injury site metabolism would improve limb power. To determine causation, we focused on grade C (American Spinal Injury Association Impairment Scale, AIS) injuries because they have some intact limb power below the injury. Limb motor score, ISP, SCPP, and injury site lactate-to-pyruvate ratio (LPR) were monitored for up to a week after surgery. We used these time series to investigate the hypothesis that fluctuations in motor score are caused by fluctuations in the physiology and metabolism at the injury site. We employed the concept of causality proposed by Clive Granger [27] and recently reviewed [28], i.e., a variable, such as SCPP, which evolves in time, Granger-causes another time-evolving variable, such as motor score, if predictions of motor score based on its own past and on the past of SCPP are better than predictions of motor score based solely on its own past.
Methods
Institutional Research Board Approvals
Injured Spinal Cord Pressure Evaluation (ISCoPE) is a clinical study at St. George’s Hospital in London, U.K., registered at www.clinical trials.gov as NCT02721615. Approvals for the ISCoPE study including the consent form and patient information sheet were obtained by the St. Georges Joint Research Office and the U.K. National Research Ethic Service—Camberwell St Giles Committee (No 10/H0807/23). The study has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all individual participants included in the study.
Study Design
We investigated the correlations and causal relations between ISP, SCPP, tissue LPR, glutamate, and standardized motor score in AIS C TSCI patients.
Inclusion/Exclusion Criteria
We selected all AIS grade C TSCI patients who were enrolled into ISCoPE for the period October 2011–January 2020. Inclusion criteria for ISCoPE are: severe TSCI grades A–C, age 18–70 years and surgery performed within 72 h of injury. Exclusion criteria are: major co-morbidity, inability to obtain consent, and penetrating TSCI. The ISCoPE study initially aimed to develop ISP monitoring from the injury site. In 2014, we also started monitoring MD. The current study includes AIS grade C patients who only had ISP monitoring (recruited 2011–4) as well as those who also had MD monitoring (recruited 2014–2020).
Clinical Examination and Imaging
All patients were admitted to the neurosurgical unit at St. George’s Hospital and underwent International Standards for Neurological Classification of Spinal Cord Injury assessments by a trained neurosurgical resident, which was repeated at discharge and in follow-up clinic. Postoperatively, all patients were admitted to the Neuro-ICU. As standard clinical care in our unit, all TSCI patients undergo regular motor limb assessments by nurses trained in Medical Research Council grading of limb power. These assessments were performed with the patient off sedation or during a sedation hold and recorded in spinal assessment charts. Patients had CT and MRI of the spine before surgery and within four weeks of surgery.
Probe Insertion
Surgical decompression and spinal instrumentation were performed by a neurosurgeon based on patient requirements and surgeon preference. Surgical decompression was laminectomy with or without corpectomy with spinal instrumentation based on surgeon preference. Posterior fixation was with lateral mass screws for the cervical spine and pedicle screws for the thoracic spine. Anterior cervical fixation was with vertebral body plate and screws. During the posterior approach, a pressure probe (Codman Microsensor Transducer®, Depuy Synthes, Leeds, UK) and a MD catheter (CMA61: CMA microdialysis AB, Solna, Sweden) were placed intradurally on the surface of the injured cord at the site of maximal cord swelling based on the preoperative MRI (Fig. 1). The dural opening was sutured and supplemented with fibrin glue (Tisseel®, Baxter, UK). Postoperative CT with the probes in situ confirmed positioning.
Intraspinal Pressure and Blood Pressure Monitoring
The pressure probe was connected to a Codman ICP box linked via a ML221 amplifier to a PowerLab running LabChart v.8 (AD Instruments, Oxford, UK). Blood pressure was recorded from a radial artery catheter connected to the Philips Intellivue MX800 bedside monitoring system (Philips, Guildford, UK), in turn connected to the PowerLab system. ISP and blood pressure signals were sampled at 1 kHz, and patients were monitored for up to a week. Data were analyzed using Labchart version 8 (AD Instruments, Oxford, UK) and ICM+ (www.neurosurg.cam.ac.uk/icmplus). We computed SCPP as MAP–ISP. ISP is different from intrathecal pressure measured above or below the injury because the swollen, injured cord is compressed against the dura thus compartmentalizing the intrathecal space as illustrated in Fig. 1a and described in earlier publications [29,30,31].
Microdialysis Setup and Analysis
MD was started postoperatively in the Neuro-ICU as described [22, 23, 25]. Central nervous system fluid (CMA microdialysis AB) was perfused at 0.3 μL/min using the CMA106 pump (CMA microdialysis AB). MD vials were changed hourly and analyzed using ISCUS Flex (CMA microdialysis AB) for glucose, lactate, and pyruvate. The LPR was calculated. The first two samples from each patient were discarded to allow priming of the MD catheter and stabilization of the metabolite concentrations. 100-fold changes in metabolite concentration, compared with the preceding hour, were excluded from analysis. Metabolite levels were compared to corresponding hourly averages of ISP, MAP, and SCPP. Our MD method measures spinal cord surface metabolism at the injury site, which correlates with intraparenchymal injury site metabolism, but is different from metabolites measured from lumbar cerebrospinal fluid [22, 23, 32].
Standardization of Limb Motor Score
The motor scores in the spinal assessment charts were standardized by subtracting the minimum postoperative motor score for each patient from all motor scores for that patient. Standardized motor scores were compared to ISP, MAP, SCPP, and MD values averaged over the hour corresponding to the neurological assessment.
Summary of Variables/Outcomes
We obtained matched values of ISP, SCPP, tissue glucose, LPR, and standardized motor score. To avoid bias, data were analyzed blindly, i.e., each variable/outcome was obtained and listed for analysis without knowledge of the other associated variables.
Statistical Analysis
Motor score (y) versus ISP (x) was fitted with an exponential decay curve \(y=A+B{e}^{-Cx}\), motor score versus SCPP and versus LPR were fitted with linear equations, whereas motor score (y) versus MAP (x) was fitted with a bounded exponential curve \(y=A+B(1-{e}^{-Cx})\) using the online free curve fitting service (https://mycurvefit.com/). Plots are mean ± standard error. For Granger causality analysis of the standardized motor score, ISP, SCPP, and LPR time series, we used the Granger function in the Cloud Causal Analytics Toolkit (https://cox-associates.com/) that employs vector autoregression models to test for causal relations. For details, see Supplement.
Results
Participants
There were 19 patients, with average age 47 years (range 19–70), of which 14 (74%) were male and 5 (26%) female. Fourteen (74%) had cervical and 5 (26%) thoracolumbar injuries. Of the 19 patients, 12 (63%) had posterior surgical approach plus laminectomy, 5 had anterior plus posterior approach and laminectomy (26%) and 2 (11%) had posterior approach without laminectomy. Mean time from injury to surgery was 38 h. All 19 patients had ISP monitoring and 13 (68%) also had MD monitoring. The mean duration of ISP monitoring was 5.1 days (range 1.8–6.8) and of MD monitoring 3.7 days (range 0–6.8). The mean number of motor exams in the monitored period was 19 (range 5–37). Table 1 has details.
Complications
Two patients (11%) had cerebrospinal fluid leak from around the probe skin exit site which stopped with additional sutures, and 4 patients (21%) had asymptomatic pseudomeningocele on the postoperative MRI. Four patients (21%) had chest sepsis, and 1 (5.3%) patient developed Korsakoff psychosis from alcohol withdrawal.
Motor Score Strongly Correlates with Injury Site Physiology
Figure 2 shows the relations between standardized motor score versus ISP, versus SCPP, and versus MAP using data from all 19 patients. The curve \(y=3.9+33.4{e}^{-1.1x}\) fits well with the relation between average motor score (y) versus ISP class (x = 1, …, 8, respectively, defined as < 5, …, 35 – 40 mmHg). Reduction in ISP from > 20 to < 5 mmHg is associated with an average gain of about 11 motor points, whereas fluctuations in ISP in the range 20–40 mmHg are not associated with changes in average motor score. The line \(y=1.4x-3.9\) fits well with the relation between average standardized motor score (y) versus SCPP class (x = 1, …, 7, respectively, defined as 40–50, …, 100–110 mmHg). Increasing SCPP from < 50 mmHg, up to 110 mmHg, is associated with an average gain of about 8–9 motor points. Increasing SCPP beyond 110 mmHg is associated with a reduction in motor score. The curve \(y=-0.1+6.0(1-{e}^{-0.4x})\) fits well with the relation between average standardized motor score (y) versus MAP class (x = 1, …, 11, respectively, defined as < 75, …, > 120 mmHg). Increase in MAP from < 75 to 95 mmHg is associated with an average gain of about 4 motor points, whereas fluctuations in MAP in the range 95–130 mmHg are not associated with changes in average standardized motor score.
Motor Score Strongly Correlates with Injury Site Metabolism
Figure 3 shows that the line \(y=-0.8x+8.3\) fits well with the relation between average standardized motor score (y) versus LPR class (x = 2, …, 6, respectively, defined as 20–30, …, > 70), plotted using data from the 13 patients who had MD monitoring. Reducing the LPR from > 70 to 20–30 is associated with an average gain of about 4 motor points. Reducing the LPR below 20 is associated with a reduction in average standardized motor score. Increasing the LPR from 20–30 to 30–40 was associated with no change in pyruvate but increase in lactate. As LPR increases beyond 50, both pyruvate and lactate drop.
Injury Site Physiology and Metabolism Are Closely Related
Figure 4 shows how ISP is related to injury site metabolism. LPR (y) and ISP class (x = 1, …, 9, respectively, defined as < 5, …, > 40 mmHg) positively correlate according to \(y=5.0x+20.5\). As ISP increases, glucose increases, whereas lactate and pyruvate fall. Figure 5 shows how SCPP is related to injury site metabolism. LPR (y) and SCPP class (x = 1, …, 8, respectively, defined as < 60, …, > 120 mmHg) negatively correlate according to \(y=-4.3x+54.3\). As SCPP increases up to 110 mmHg, glucose remains constant, whereas lactate and pyruvate slightly increase. As SCPP increases beyond 110 mmHg, glucose and pyruvate rise, whereas lactate falls.
Causality Analysis
Granger-causal relations between the motor score, ISP, SCPP, and LPR time series are illustrated in Fig. 6. Increasing LPR Granger-causes increased ISP, decreased SCPP, and decreased motor score. In other words, worse injury site metabolism increases cord swelling, reduces cord perfusion, and increases limb weakness. Increasing SCPP Granger-causes decreased LPR and increased motor score. In other words, improving spinal cord perfusion improves spinal cord metabolism and improves limb weakness. Increasing ISP Granger-causes increased LPR, decreased SCPP, and decreased motor score. In other words, increased cord swelling reduces cord perfusion, worsens cord metabolism, and increases limb weakness.
Discussion
Key Results
We showed that, after spinal cord injury, fluctuations in injury site physiology (cord edema, cord perfusion) and metabolism (LPR) Granger-cause fluctuations in limb power. These causal relations between events at the injury site and limb power were established by monitoring patients with acute, motor-incomplete spinal cord injuries.
Limitations
Though the study has a relatively small number of patients (19), our conclusions are supported by a large amount of monitoring data including 2,306 h of ISP and SCPP monitoring, 1,703 h of MD monitoring and 366 motor examinations. Another issue is that causality is a deeply philosophical concept with many possible answers that do not satisfy everyone, compared with our definition of causality, which is purely mathematical.
Granger Causality
Establishing causation in medicine is based on the totality of evidence that includes strong association, biological mechanism, consistent finding, temporal sequence, and dose–response [33]. In the absence of a randomized trial, which is considered the “gold standard” to establish causation [34, 35], we investigated causal relations in our observational data using Granger analysis [27, 28]. Granger’s definition of causality, initially developed for financial forecasting, satisfies two intuitive notions: First, the cause always precedes the effect. Second, the cause carries unique information about the future effect, i.e., there is information flow from the past of the cause to the future of the effect that cannot be accounted for by the past of the effect. Implicit in these notions is that intervention to alter the cause should result in a predictable change in the future of the effect. Advantages of Granger are that it is expressed in relatively straightforward mathematics that permit hypothesis testing and provide information about the strength of each causality [34, 35]. Alternative analyses that can distinguish between causation and correlation may be performed, e.g., convergent cross mapping, which is based on complexity theory and, unlike Granger, does not assume linear relations [36].
Interpretation of Correlations
Multiple correlations between injury site physiology, metabolism, and neurological status were defined. Here, we highlight some interesting findings: First, optimal ISP is less than 5 mmHg, i.e., no cord compression. Second, increase in ISP from 20 to 40 mmHg is associated with increase in LPR, but no reduction in limb power, probably because the standardized motor score is already very low. Third, as SCPP increases, LPR decreases (less ischemia) and limb power improves but, beyond 110 mmHg, limb power decreases, suggesting that hyper-perfusing the injury site is detrimental. Metabolically, hyper-perfusion is characterized by very low (less than 20) LPR and high glucose; though this is aerobic metabolism, our data suggest that the high glucose is detrimental as previously reported [37,38,39] due to increased endoplasmic reticulum stress, inflammation and free radicals. Fourth, increasing the MAP beyond 85–90 mmHg, which remarkably corresponds to the recommended target [40], does not improve limb power. A possible explanation is that low MAP indicates injury site ischemia regardless of ISP, but above 90 mmHg, the same MAP corresponds to injury site ischemia in some patients and hyper-perfusion in others. In practical terms, increasing the SCPP improves limb power more than increasing the MAP. Fifth, the correlations between ISP and SCPP versus limb power are reminiscent of similar relations versus neurological improvement at 9–12 months [20]. Sixth, though there is inverse correlation between LPR and limb power, LPR below 20 appears detrimental likely related to hyper-perfusion state described above. Seventh, as LPR increases up to 50–60, pyruvate decreases and lactate increases (indicating compensatory switch from aerobic to anaerobic metabolism at the injury site), but as LPR increases beyond 60, both pyruvate and lactate decrease (indicating overall suppression of aerobic and anaerobic metabolism). Though the findings described here provide a unique insight into how spinal cord physiological and metabolic events relate to limb power, they are associations that do not imply causations.
Interpretation of Causal Effects
The causal relations between LPR, SCPP, ISP, and standardized motor score in Fig. 6 make biological sense. A metabolic insult (high LPR, e.g., from hypoxia or infection) Granger-causes cord swelling (high ISP), Granger-causes reduction in cord perfusion, and Granger-causes impaired neuronal function (reduced motor score). Increase in spinal cord perfusion Granger-causes increase in aerobic metabolism at the injury site (decreased LPR) and Granger-causes the motor score to improve. Cord swelling (increase in ISP) Granger-causes more anaerobic metabolism (LPR increases), Granger-causes drop in SCPP (= MAP – ISP) and Granger-causes reduction in limb power. Interestingly, Granger analysis did not produce absurdities, e.g., change in limb power Granger-causes physiological or metabolic changes at the injury site. A key finding in Fig. 6 is several positive feedback loops (vicious cycles), e.g., increased LPR Granger-causes increased cord swelling, in turn Granger-causing increase in LPR. Multi-step vicious cycles are also evident, e.g., increased LPR Granger-causes increased cord swelling, which Granger-causes decreased SCPP, in turn Granger-causing increase in LPR. The presence of so many vicious cycles implies that insults to the injury site (e.g., hypoxia, acidosis, etc.) are amplified, thus emphasising the importance of treating such insults to prevent secondary cord damage.
Implications for Treatment
ISP is increased by cord compression from bone fragments, hematoma, and dura. Decompression of the injured cord including duroplasty would reduce ISP [41]. MAP may be increased using vasopressors [30]. Reducing ISP and increasing MAP will, in turn, increase SCPP. Interventions to reduce LPR (other than reducing ISP and increasing SCPP) include management of hypoxia, fever, and acidosis (e.g., limiting blood loss during surgery) [21, 32].
Generalizability
To study the relations between physiological/metabolic events at the injury site and limb power, we focused here only on AIS C TSCI patients. Our key conclusion that reducing ISP, increasing SCPP, and reducing LPR improve neurological status is likely to apply to all injury severities. Future studies may explore this further, e.g., by determining the effect of increasing SCPP on sensory level in AIS A and B TSCI patients.
Conclusions
The causal relationships described here suggest that interventions to normalize LPR, SCPP, and ISP are likely to improve limb power in AIS C TSCI patients.
References
Lee BB, Cripps RA, Fitzharris M, Wing PC. The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. Spinal Cord. 2014;52:110–6.
Centre NSS. Spinal cord injury facts and figures at a glance. J Spinal Cord Med. 2014;37:659–60.
Fehlings MG, Vaccaro A, Wilson JR, et al. Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS ONE. 2012;7:e32037.
Batchelor PE, Wills TE, Skeers P, et al. Meta-analysis of pre-clinical studies of early decompression in acute spinal cord injury: a battle of time and pressure. PLoS ONE. 2013;8:e72659.
Wagner FC Jr, Chehrazi B. Early decompression and neurological outcome in acute cervical spinal cord injuries. J Neurosurg. 1982;56:699–705.
Dvorak MF, Noonan VK, Fallah N, et al. The influence of time from injury to surgery on motor recovery and length of hospital stay in acute traumatic spinal cord injury: an observational Canadian cohort study. J Neurotrauma. 2015;32:645–54.
Wilson JR, Singh A, Craven C, et al. Early versus late surgery for traumatic spinal cord injury: the results of a prospective Canadian cohort study. Spinal Cord. 2012;50:840–3.
Bracken MB, Collins WF, Freeman DF, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA. 1984;251:45–52.
Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322:1405–11.
Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277:1597–604.
Otani K AH, Kadoya S, Nakagawa H, Ikata T, Tominaga S. Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury. Sekitsui Sekizui 1994:633–47.
Fehlings MG, Wilson JR, Tetreault LA, et al. A clinical practice guideline for the management of patients with acute spinal cord injury: recommendations on the use of methylprednisolone sodium succinate. Global Spine J. 2017;7:203S–S211211.
Tator CH, Rowed DW, Schwartz ML, et al. Management of acute spinal cord injuries. Can J Surg. 1984;27(289–93):96.
Vale FL, Burns J, Jackson AB, Hadley MN. Combined medical and surgical treatment after acute spinal cord injury: results of a prospective pilot study to assess the merits of aggressive medical resuscitation and blood pressure management. J Neurosurg. 1997;87:239–46.
Jacobs WB. Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury (MAPS). ClinicalTrials.gov; 2014:02232165.
Levi L, Wolf A, Belzberg H. Hemodynamic parameters in patients with acute cervical cord trauma: description, intervention, and prediction of outcome. Neurosurgery. 1993;33:1007–16 discussion 16–7.
Wilson JR, Forgione N, Fehlings MG. Emerging therapies for acute traumatic spinal cord injury. CMAJ. 2013;185:485–92.
Saadoun S, Papadopoulos MC. Spinal cord injury: is monitoring from the injury site the future? Crit Care. 2016;20:308.
Chen S, Smielewski P, Czosnyka M, Papadopoulos MC, Saadoun S. Continuous monitoring and visualization of optimum spinal cord perfusion pressure in patients with acute cord injury. J Neurotrauma. 2017;34:2941–9.
Saadoun S, Chen S, Papadopoulos MC. Intraspinal pressure and spinal cord perfusion pressure predict neurological outcome after traumatic spinal cord injury. J Neurol Neurosurg Psychiatry. 2017;88:452–3.
Hogg FRA, Gallagher MJ, Chen S, Zoumprouli A, Papadopoulos MC, Saadoun S. Predictors of intraspinal pressure and optimal cord perfusion pressure after traumatic spinal cord injury. Neurocrit Care. 2019;30:421–8.
Phang I, Zoumprouli A, Papadopoulos MC, Saadoun S. Microdialysis to optimize cord perfusion and drug delivery in spinal cord injury. Ann Neurol. 2016;80:522–31.
Chen S, Phang I, Zoumprouli A, Papadopoulos MC, Saadoun S. Metabolic profile of injured human spinal cord determined using surface microdialysis. J Neurochem. 2016;139:700–5.
Phang I, Zoumprouli A, Saadoun S, Papadopoulos MC. Safety profile and probe placement accuracy of intraspinal pressure monitoring for traumatic spinal cord injury: injured spinal cord pressure evaluation study. J Neurosurg Spine. 2016;25:398–405.
Gallagher MJ, Zoumprouli A, Phang I, et al. Markedly deranged injury site metabolism and impaired functional recovery in acute spinal cord injury patients with fever. Crit Care Med 2018.
Werndle MC, Saadoun S, Phang I, et al. Monitoring of spinal cord perfusion pressure in acute spinal cord injury: initial findings of the injured spinal cord pressure evaluation study. Crit Care Med. 2014;42:646–55.
Granger CWJ. Investigating causal relations by econometric models and cross-spectral methods. Econometrica. 1969;37:424–38.
Seth AK, Barrett AB, Barnett L. Granger causality analysis in neuroscience and neuroimaging. J Neurosci. 2015;35:3293–7.
Werndle MC, Saadoun S, Phang I, et al. Measurement of intraspinal pressure after spinal cord injury: technical note from the injured spinal cord pressure evaluation study. Acta Neurochir Suppl. 2016;122:323–8.
Werndle MC, Saadoun S, Phang I, et al. Monitoring of spinal cord perfusion pressure in acute spinal cord injury: initial findings of the injured spinal cord pressure evaluation study*. Crit Care Med. 2014;42:646–55.
Varsos GV, Werndle MC, Czosnyka ZH, et al. Intraspinal pressure and spinal cord perfusion pressure after spinal cord injury: an observational study. J Neurosurg Spine. 2015;23:763–71.
Gallagher MJ, Zoumprouli A, Phang I, et al. Markedly deranged injury site metabolism and impaired functional recovery in acute spinal cord injury patients with fever. Crit Care Med. 2018;46:1150–7.
Hennekens CH, DeMets D. Statistical association and causation: contributions of different types of evidence. JAMA. 2011;305:1134–5.
Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312:1215–8.
Sanson-Fisher RW, Bonevski B, Green LW, D'Este C. Limitations of the randomized controlled trial in evaluating population-based health interventions. Am J Prev Med. 2007;33:155–61.
Sugihara G, May R, Ye H, et al. Detecting causality in complex ecosystems. Science. 2012;338:496–500.
Chen Z, Guo H, Lu Z, Sun K, Jin Q. Hyperglycemia aggravates spinal cord injury through endoplasmic reticulum stress mediated neuronal apoptosis, gliosis and activation. Biomed Pharmacother. 2019;112:108672.
Kobayakawa K, Kumamaru H, Saiwai H, et al. Acute hyperglycemia impairs functional improvement after spinal cord injury in mice and humans. Sci Transl Med. 2014;6:256ra137.
Park KS, Kim JB, Keung M, et al. Chronic hyperglycemia before spinal cord injury increases inflammatory reaction and astrogliosis after injury: human and rat studies. J Neurotrauma 2020.
Walters BC, Hadley MN, Hurlbert RJ, et al. Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update. Neurosurgery. 2013;60:82–91.
Phang I, Werndle MC, Saadoun S, et al. Expansion duroplasty improves intraspinal pressure, spinal cord perfusion pressure, and vascular pressure reactivity index in patients with traumatic spinal cord injury: injured spinal cord pressure evaluation study. J Neurotrauma. 2015;32:865–74.
Acknowledgements
We thank the neurosurgeons at St. George’s Hospital, King’s College Hospital and Hurstwood Park Neurological Centre as well as the spinal orthopaedic surgeons at St. George’s Hospital who helped recruit patients. The neuroanaesthetic, Neuro-ICU, and operating theatre staff at St. George’s Hospital helped with data collection.
Funding
Supported by grants to SS and MCP from Wings for Life Spinal Cord Research Foundation and to MCP from the Neurosciences Research Foundation (Fletcher Fund). FRAH is a Royal College of Surgeons of England research fellow. SK is supported by NIHR CRN.
Author information
Authors and Affiliations
Contributions
FRAH collected and analyzed data. SK collected data. AZ anesthetized the patients and looked after them in the ICU. MCP operated on the patients and had overall responsibility for their clinical care. SS analyzed data, plotted graphs, wrote the manuscript and had overall supervision of the project. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
All authors have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Marios C. Papadopoulos and Samira Saadoun: Co-senior authors.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hogg, F.R.A., Kearney, S., Zoumprouli, A. et al. Acute Spinal Cord Injury: Correlations and Causal Relations Between Intraspinal Pressure, Spinal Cord Perfusion Pressure, Lactate-to-Pyruvate Ratio, and Limb Power. Neurocrit Care 34, 121–129 (2021). https://doi.org/10.1007/s12028-020-00988-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-020-00988-2